Thoracic audit update SCTS Board of Representatives

Slides:

Advertisements

Similar presentations

Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.

Advertisements

National Prostate Cancer Audit Julie Nossiter, Project Manager Clinical Effectiveness Unit – Royal College of Surgeons.

National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.

The European Perfusion Registry: A Work in Progress Luc Puis, ECCP Ian Johnson, AACP Else Nygreen, ECCP Pia Sprogøe, ECCP Tim Jones, MB BS, MD, FRCS ICEBP.

The National Survey of Reasonable Adjustments by NHS Trusts 2010 Results and recommendations Hazel Roberts, Chris Hatton and Sue Turner.

March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.

Towards a ANZ Hip Fracture Registry “Quality Care Costs Less”

The LCA: Implementing a Quality Assurance and Informatics Strategy to Enhance Cancer Care Dr Shelley Dolan LCA Clinical Director.

October 2004 Screening and Surveillance of routine data Adrian Cook.

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.

Acute Quality Standards Dan Beckett Acute Physician CMO Advisor for Acute & General Medicine.

Surgeon Specialty and Operative Mortality With Lung Resection PP Goodney, FL Lucas, TS Stukel, JD Birkmeyer VA Outcomes Group, White River Junction, VT.

AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update.

LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.

Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,

How to Practice Thoracic Surgery in the Pay for Quality Era Douglas E. Wood Alessandro Brunelli Stephen D Cassivi Claude Deschamps Shaf Keshavjee Cameron.

Cancer Outcomes and Services Data collection Implementation SIG Denise Downs, Implementation and Education Lead, UK.

The National Emergency Laparotomy Audit Dave Murray National Clinical Lead

Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.

Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.

How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.

Why have a national database? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester University and Manchester.

Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.

How clinicians use data to make an impact on clinical outcomes

Thoracic Surgery Update 2016

Delivery of systemic therapy in Gloucestershire for NSCLC

NHSE Commissioning update

July 2016 update from the National Cancer Registration and Analysis Service Local The NCRAS Local Group for Intelligence on Cancer (LoGIC), a group of.

Title Introduction Methods Results Discussion Authors

A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani.

Curative treatment rates for patients diagnosed with

National data in thoracic surgery

Segmented analysis of prostate cancer pathway from referral to treatment: This work was carried out in partnership between the Transforming.

Specialised Services: harm and mortality reduction

Blackpool presentation

Mortality and harm reduction in Cwm Taf Health Board

NCEPOD Launch Too Lean a Service

Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November

National Lung Cancer Audit

Current UK and EACTS database initiatives

Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.

Semiannual Report, March 2015

NHS England Service Specification for Thoracic Surgery (Adult)

Surgical update.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Hannah Marder Cancer Manager UH Bristol

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

2018 National Mesothelioma Audit

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Early Results After Regionalization of Thoracic Surgical Practice in a Single-Payer System Sudhir Sundaresan, MD, Robin McLeod, Jonathan Irish, Judy.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Headquarters | Royal Free London NHS Foundation Trust | UK

Thomas J. Watson, MD, Jiejing Qiu, MS The Annals of Thoracic Surgery

National Emergency Laparotomy Audit

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Pulmonary Resection for Lung Cancer in Octogenarians

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Is there a role for pneumonectomy in pulmonary metastases?1

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

MDT scorecard – using routine data to reduce unwarranted variations

National Lung Cancer Audit

National data in surgery: LCCOP 2018(2016)

Surgical resection update

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Presentation transcript:

Thoracic audit update SCTS Board of Representatives 6th October 2016 London Doug West thoracic audit lead

Overview The LCCOP project and 2014 report The third thoracic blue book and database Collaboration with RCSEng Clinical Evaluation Unit HES based pilot audit

LCCOP Third (2014) data report Report due early December 2016 Uses COSD (old LUCADA) and now HES data Risk adjustment Novel model Models for 30 and 90 day mortality

Outcomes Unit Individual Extended outcomes 30 day adjusted mortality Names of lung MDTs a surgeon routinely covers Resection rates of those MDTs (likely 2015 NLCA) Extended outcomes Resection rate stage 1-2, performance status 0-1

LCCOP 2014 data report Data validation

Reflections All units returned validated data on time Shorter time available “Leap year” Problems Passwords Request for MDT data unclear

Data validation: still needed

Data validation: a London effect? Data courtesy Natasha Wood, NCRAS, Public Health England

Questions for future rounds New outcomes measures One year survival Process of care outcomes Pneumonectomy rates

Third Blue Book Funded by Johnson and Johnson Registry data 1980-2015 3 years of SCTS database Open up SCTS data to analysis by member units and collaborators

Third Blue Book: 35 years of progress…

Collaboration with RCSEng Clinical Evaluation Unit Can HES provide useful audit data at unit level? SCTS funded pilot study Pneumothorax and pleural sepsis surgery Outcomes: mortality, LoS, readmission, reoperation

Thoracic audit update: BORS 2016 ThanK you